Cited by 1,011Inflammatory mediators and NSAID effectsReceptor Mechanisms and SignalingEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Prostanoid Receptors: Subtypes and Signaling

Breyer, Richard M, Bagdassarian, Carey K, Myers, Scott A, Breyer, Matthew D·2001·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.41.1.661

Open this paper in CoChat — free account

Abstract

Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.41.1.661

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677

Show all 152 references

Research works printed but not linked: 18

Coleman RA, 1994, Pharmacol. Rev., 46, 205
Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
Funk CD, 1993, Mol. Pharmacol., 44, 934
Sakamoto K, 1994, J. Biol. Chem., 5, 3381
Fujino H, 2000, Mol. Pharmacol., 57, 353
Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
Regan JW, 1994, Mol. Pharmacol., 46, 213
Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
10.1042/0264-6021:3400365 · DOI
Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
Edwards RM, 1985, Am. J. Physiol., 248, F779
Kotani M, 1995, Mol. Pharmacol., 48, 869

Sorted by citations

Items 901–1,000 of 1,000

Regulação da expressão de FASL e sobrevivência dos linfócitos T CD4+ pela PGE2 durante a apresentação antigênica.
Campopiano, J. C. (2014) · doi:10.11606/t.42.2014.tde-14032015-093702
Papel dos leucotrienos na proteção conferida pela imunização heteróloga BCG/DNA-HSP65 contra tuberculose
Franco, L. H. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2009.tde-27102009-174027
ROLE OF PROSTAGLANDIN E2 IN THE REGULATION OF PANCREATIC STELLATE CELLS HYPER ACTIVITY ASSOCIATED WITH PANCREATIC CANCER
Charo, C. (2011) · Digital Commons-TMC (Texas Medical Center)
Efeito da deficiência da molécula B2-integrina na produção de mediadores lipídicos e na resposta imune durante infecção experimental por Leishmania amazonensis
Pagliarone, A. C. (2014) · doi:10.11606/t.17.2014.tde-31072014-101629
Paper de la 2-ciclooxigenasa i la 5-lipooxigenasa en la inflamació hepàtica i del teixit adipós
Saura, R. H. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
mPGES-1: a key regulator of fever and neonatal respiratory depression
Saha, S. (2006) · Figshare
Avaliação das prostaglandinas e leucotrienos na infecção pulmonar induzida por Achromobacter xylosoxidans
Prado, M. K. B. (2014) · doi:10.11606/d.17.2014.tde-21052014-100327
DP Prostanoid Receptor
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60084-4
The Role of Podocyte Prostaglandin E2 and Angiotensin II Receptors in Glomerular Disease
Stitt-Cavanagh, E. M. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4446
The Effect of Exercise on Endothelial Function in Postprandial Lipemia
Thompson, B. C. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Endothelial Regulation of Pulmonary Vascular Tone
Chan, S. Y., & Loscalzo, J. (2010) · Springer eBooks · doi:10.1007/978-0-387-87429-6_11
The Expression and Function of Native EP and FP Prostanoid Receptors in Cultured Cells Derived from the Human Brain and Eye
Hutchinson, A. J. (2009) · UA Campus Repository (The University of Arizona)
Regulação da expressão gênica de FASL pela PGE2 em linfócitos T CD4+: papel do repressor transcricional ICER.
de Souza, C. N. (2014) · doi:10.11606/d.42.2014.tde-11072014-094856
Regulação do CD95L por PGE2 e seu impacto na morte de linfócitos T.
Weinlich, R. (2008) · doi:10.11606/t.42.2008.tde-19112008-171500
LIPID MEDIATORS | Prostanoids
Peters-Golden, M. L. (2006) · Elsevier eBooks · doi:10.1016/b0-12-370879-6/00120-4
Central Nervous System and Innate Immune Mechanisms for Inflammation- and Cancer-induced Anorexia
Ruud, J. (2012) · DiVA (Linkoping University)
Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders
Rahnama’i, M. S., van Koeveringe, G. A., & Kerrebroeck, P. V. (2013) · Nephro-Urology Monthly · doi:10.5812/numonthly.14088
Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk
Smith, H. S. (2006) · Journal of Cancer Pain & Symptom Palliation · doi:10.1300/j427v02n03_02
Effects of norepinephrine or prostaglandin E2 on extracellular acidification rate of MCG 101, or K1735-M2 tumor cells
Nylund, G., Andersson, M., Haraldsson, B. S., & Delbro, D. S. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.007
Physiologie und Pathologie des Geburtsbeginns
Schneider, H., Husslein, P.-W., & Schneider, K. T. M. (2011) · Springer eBooks · doi:10.1007/978-3-642-12974-2_23
Prostaglandin E2 signaling pathways in human myometrial cells
Levinson, H. S. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27465
Defining the mechanism of prostaglandin E₂-enhanced hematopoietic stem and progenitor cell homing
Speth, J. M. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1723
la gonade embryonnaire et pathologique
Malki, S., Declosmenil, F., Farhat, A., Moniot, B., Poulat, F., & Boizet‐Bonhoure, B. (2008)
skeletal muscle adaptations to exercise Effects of prostaglandins and COX-inhibiting drugs on
Trappe, T. A., Liu, S. Z., Markworth, J. F., Vella, L. D., Figueiredo, V. C., Cameron‐Smith, D., Broderick, T. L., Carroll, C. C., Martineau, K., Arthur, K. A., et al. (2015)
Prostanoids and colorectal cancer
Asting, A. G. (2010)
CRISTIANE NAFFAH DE SOUZA REGULAÇÃO DA EXPRESSÃO GÊNICA DE FASL PELA PGE2 EM LINFÓCITOS T CD4 + : PAPEL DO REPRESSOR TRANSCRICIONAL ICER
Paulo, S., & Mendes, A. (2014)
Einfluss von Prostaglandin E2 und dem transformierenden Wachstumsfaktor-β auf die plasmazytoide dendritische Zelle
München, L.-M.-U. (2007)
Adenovirus Triggers Reorganization of Vimentin-Containing Intermediate Filaments Resulting in the Perinuclear Movement of cPLA2 and Suppression of Prostaglandin Production
Culver, C. A. (2008) · NCSU Libraries Repository (North Carolina State University Libraries)
Suppression of Epithelial-Mesenchymal Transition by Prostaglandin E2 in Retinal Pigment Epithelial Cells
Orita, T., Kimura, K., Kohata, Y., Sakuma, A., Fujitsu, Y., Wakuta, M., & Sonoda, K. H. (2016) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1600039
Efeito de inibidores de proteínas quinases sobre a resposta febril e a expressão de proteínas em ratos
Molecular, P. (2013)
Fracture healing with an EP-2 agonist.
Dd, T. (2003) · PubMed
The Prostanoid EP4 receptor in prostacyclin sensing by pulmonary arterial smooth muscle cells in Monocrotaline-induced pulmonary hypertension in rats
Lai, Y., & Justus Liebig University Giessen (2008) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-13418
Prostaglandina E2 inibe a diferenciação de células Th17 no contexto de fagocitose de células apoptóticas infectadas
Verdan, F. F. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-07012016-154146
Immune Mediators of Murine Lyme Arthritis
Cunningham, A. M. (2014) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/45872
Effect of electroacupuncture on E-prostanoid 2 expression in the spinal cord in rats with neuropathic pain.
Ji, L.-L., Jiang, H.-L., Ren, X.-J., Guo, M.-W., Ge, D.-Y., Li, G.-M., & Tu, Y. (2017) · 中医杂志：英文版 · doi:10.1016/s0254-6272(17)30156-5
Systems Biology Approach to Identifying Host Interactive Pathways Modulating the Severity of Streptococcal Sepsis
Abdeltawab, N. F. (2010) · doi:10.21007/etd.cghs.2010.0003
The Role of Lipid Mediator Prostaglandin E2 in Early Neuronal Development
Davidson, J. M. (2015) · YorkSpace (York University)
Production sélective et directionnelle des prostaglandines dans l'endomètre
Lacroix‐Pepin, N. (2014)
EP-4 Prostanoid Receptor
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60337-x
EP-3 Prostanoid Receptor
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60336-8
EP-2 Prostanoid Receptor
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60090-x
The Effects of Chronic Prophylactic Naproxen Sodium on Skeletal Muscle Adaptation to Resistance Exercise in Recreationally-Trained College-Aged Males
Brewer, C. B. (2011)
Estudos de efeitos de uma metaloproteinase de veneno ofídico em células de músculo liso vascular: produção de fatores que modulam a migração e proliferação destas células e mecanismos e
Viana, M. D. N. (2019) · doi:10.11606/t.42.2019.tde-18042019-145015
Prostanoids
Nicolaou, A. (2012) · Elsevier eBooks · doi:10.1533/9780857097934.197
The Exploration of an Effective Medical Countermeasure Enhancing Survival and Hematopoietic Recovery and Preventing Immune Insufficiency in Lethally-Irradiated Mice
Wu, T. (2020) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2032
The Impact of Impaired Cyclooxygenase-2 Activity on Mouse Brain Development: A Focus on Sex Differences
Sterling, K. (2020) · York University Digital Library (York University)
Early and late changes in endothelial dependent vascular relaxation and contraction responses in the microcirculation of diabetic rats
Munisamy, S. (2020) · Universiti Sains Malaysia Institutional Repository (Universiti Sains Malaysia)
Activation of novel signal transduction pathways by human EP1 prostanoid receptors: The G-protein coupled receptors for prostaglandin E2
Ji, R. (2010) · UA Campus Repository (The University of Arizona)
Effect of Dietary Treatment with Stearidonic Acid and Eicosapentaenoic Acid on Membrane Phospholipid Fatty Acid Composition and Glycogen-Elicited Peritoneal Neutrophil Survival in Absence or Presence of Bacterial Endotoxin
Phipps, J. E. (2005)
The Impact of Inflammation Control and Active Cancer Palliation on Metabolic Pathways Determining Tumor Progression and Patient Survival
Smedh, U., Gustafsson, A., Axelsson, H., Cahlin, C., Lönnroth, C., & Lundholm, K. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_15
Mise en évidence d'un marqueur de bon pronostic dans le glioblastome multiforme, l'enzyme mPGES-1 : identification de son produit PGE2 comme un nouvel activateur direct de la protéine pro-apoptotique Bax
Lalier-Bretaudeau, L. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Peer Review #1 of "Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder (v0.1)"
Białek, K., Czarny, P., Watała, C., Wigner, P., Talarowska, M., Gałecki, P., Szemraj, J., & Śliwiński, T. (2020) · PeerJ · doi:10.7287/peerj.8676v0.1/reviews/1
Peer Review #2 of "Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder (v0.1)"
(2020) · PeerJ · doi:10.7287/peerj.8676v0.1/reviews/2
Physiologie und Pathologie des Geburtsbeginns
Schneider, H., Helmer, H., Husslein, P. W., Egarter, C., von Steinburg, S. P., & Lengyel, E. R. (2007) · Springer eBooks · doi:10.1007/978-3-540-33897-0_24
Physiologie und Pathologie des Geburtsbeginns
Schneider, H., Helmer, H., & Husslein, P. W. (2016) · Springer eBooks · doi:10.1007/978-3-662-45064-2_28
Prostanoids
Maher, S. A., Clarke, D. L., & Belvisi, M. G. (2011) · Wiley eBooks · doi:10.1002/9781444346688.ch22
Physiologie und Pathologie des Geburtsbeginns
Schneider, H., Helmer, H., & Husslein, P. W. (2015) · Springer eBooks · doi:10.1007/978-3-662-44369-9_28-1
TP Prostanoid Receptor
Wise, H. M., & Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60087-x
Physiologie und Pathologie des Geburtsbeginns
Schneider, H., Helmer, H., Husslein, P. W., Egarter, C., von Steinburg, S. P., & Lengyel, E. R. (2004) · Springer eBooks · doi:10.1007/978-3-642-18574-8_24
Butaprost
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.61358-3
SA bioaktív lipidek és a zsírsav-bioszintézis szerepe a Candida Parapsilosis virulenciájában
Grózer, Z. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2505
Cicaprost
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.61460-6
Iloprost
Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.61917-8
Symposium
Montine, T. J. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00508.x
Receptors | Eicosanoid Receptors
BREYER, R. M., & Breyer, M. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00558-2
Self-citation
Eicosanoid Receptors
BREYER, R. M., & Breyer, M. D. (2004) · Encyclopedia of Biological Chemistry · doi:10.1016/b0-12-443710-9/00190-3
Self-citation
IP Prostanoid Receptor
Wise, H. M., & Jones, R. L. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60086-8
Prostanoid
Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706540
Features of omega-3/omega-6 fatty acid metabolism in children with epileptic encephalopathies and autism spectrum disorders
Kyrylova, L. G., Yuzva, О. О., & Miroshnikov, О. О. (2022) · Ukrainian journal of Perinatology and Pediatrics · doi:10.15574/pp.2022.90.31
Role of intraluteal and intrauterine prostaglandin signaling in LH‐induced luteolysis in pregnant rats
Vashistha, A., & Khan, H. R. (2023) · Molecular Reproduction and Development · doi:10.1002/mrd.23678
Data from Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Kaliberova, L. N., Kusmartsev, S. A., Krendelchtchikova, V., Stockard, C. R., Grizzle, W. E., Buchsbaum, D. J., & Kaliberov, S. A. (2023) · doi:10.1158/1535-7163.c.6531485.v1
The Role of HPV16 E1 in Cervical Carcinogenesis
Baedyananda, F. (2018) · doi:10.58837/chula.the.2018.28
COMBINATION EFFECT OF CEPHARANTHINE AND 5-FLUOROURACILON HUMAN COLON CANCER IN A MOUSE XENOGRAFT MODEL
Kongsaden, C., Wonganan, P., & Itthipanichpong, C. (2017) · doi:10.58837/chula.the.2017.358
Oral epithelial-derived mediators suppress RANKL expression in human mandibular-derived bone cells
Khonsuphap, P. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1739
Urinary Biomarkers of Detrusor Underactivity
Oliveira, J., Faria‐Costa, G., Charrua, A., Vale, L., Silva, J., & Antunes‐Lopes, T. (2024) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-024-00737-7
Physiologie und Pathologie des Geburtsbeginns
Mueller, M., Helmer, H., Schneider, H., Husslein, P. W., & Maul, H. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_28-2
Comparative Investigation of the Mechanisms of Calcium Response in Human and Murine Spermatozoa
Korobkina, J. D., Panteleev, M. A., & Sveshnikova, A. N. (2024) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747824700132
Physiologie und Pathologie des Geburtsbeginns
Mueller, M., Helmer, H., Schneider, H., Husslein, P. W., & Maul, H. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_28
Molecular Thumbprints: Biological Signatures That Measure Loss of Identity
Devchand, P. R., Dicay, M. S., & Wallace, J. L. (2024) · Biomolecules · doi:10.3390/biom14101271
Comparative Investigation of the Mechanisms of Calcium Response in Human and Murine Spermatozoa
Korobkina, J. D., Panteleev, M. A., & Sveshnikova, A. N. (2024) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.31857/s0233475524030086
Indirect Regulation of Na+, K+-ATPase by Arachidonic Acid-Derived Eicosanoids: Participation of Eicosanoids in the Sodium Theory for Migraine
Biringer, R. G. (2025) · Medical Research Archives · doi:10.18103/mra.v13i1.6381
The Renal Microcirculation
Navar, L. G., Arendshorst, W. J., Pallone, T. L., Inscho, E. W., Imig, J. D., & Bell, P. D. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01022.x
Receptor‐Mediated Events in the Microcirculation
Watts, S. W., Kanagy, N. L., & Lombard, J. H. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01016.x
cAMP BIOSENSORS AND SPATIOTEMPORAL cAMP SIGNALING IN ADULT CARDIAC MYOCYTES
Warrier, S. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Differential Signaling and Gene Regulation Among Three Human EP3 Prostanoid Receptor Isoforms
Israel, D. D. (2008) · UA Campus Repository (The University of Arizona)
Regulatory mechanisms of epithelial sodium channel
Wang, S. (2010) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Caffeine for prostaglandin E1-induced apnea in neonates with ductal dependent congenital heart disease: integrating evidence into practice
Iwashita-Lages, T., Sen, S. K., Chaudhry, P. M., Ball, M. K., Steurer, M. A., Krishnamurthy, G., & Levy, P. T. (2026) · Journal of Perinatology · doi:10.1038/s41372-026-02639-4
Mécanismes de régulation de la hème-oxygénase-1 et de la cyclooxygénase-2 par les statines dans les macrophages et les fibroblastes
Mrad, M. F. (2013) · doi:10.70675/862aa8e1z3e04z4d65zb92az9f759aa785f1
Implication des neurones exprimant NUCB2/nesfatine-1 dans la régulation de l'homéostasie énergétique
Bonnet, M. S. (2013) · theses.fr (ABES) · doi:10.70675/82840557z70b7z4214zbe5azca1e4f81d53a
Rôle de la voie COX-2 au cours de l'infection par Brucella
Gagnaire, A. (2016) · theses.fr (ABES) · doi:10.70675/2f54eb87za0e5z4e1dzb465z168c5d1054de
Etude des mécanismes de résistance à l'apoptose induite par l'acide ursolique dans le mélanome humain : implication de la mélanogenèse et de la voie COX-2/PGE2
Hassan, L. (2016) · doi:10.70675/080250b5z4633z46c7za848zda84426834e4
Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
Jiang, N. (2019) · theses.fr (ABES) · doi:10.70675/e788b268zc8e3z491az8d02z52080880e988
Système nerveux entérique : source de prostaglandines D2 et E2, implication dans les maladies inflammatoires chroniques de l'intestin
Loupp, A.-G. L. (2018) · theses.fr (ABES) · doi:10.70675/df3ee31fz8b68z46bcza3dfz5a5b912fe40f
Effets des prostaglandines I₂ et E₂ sur la réactivité des muscles lisses pulmonaires humains : implications pour le traitement de l’hypertension pulmonaire
Benyahia, C. (2015) · doi:10.70675/f8a490a6za714z4b59z8c47z4de8c2da839b
The Emerging Parkinson's Disease Oxylipin‐Ome
Kelliher, J. C., & Fanning, S. (2026) · Advanced Science · doi:10.1002/advs.202522997
The Functional Study of Prostaglandin E 2 via EP Receptor on Pacemaker Activity in Interstitial Cells of Cajal from Murine Colon
Gong, H., Jiao, H. Y., Chang, Y., Choi, S., Hong, C. S., & Jun, J. Y. (2026) · Chonnam Medical Journal · doi:10.4068/cmj.2026.62.2.79
Physiology and Pathology of the Onset of Labor
Mueller, M., Helmer, H., Schneider, H., Husslein, P., & Maul, H. (2026) · Springer eBooks · doi:10.1007/978-3-662-70578-0_40
BindingDB Entry 50001324: Discovery of a novel 2-(1H-pyrazolo[3,4-b]pyridin-1-yl)thiazole derivative as an EP
BindingDB (2020) · UC San Diego · doi:10.7270/q2t72kzt
BindingDB Entry 50041593: Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
BindingDB (2013) · UC San Diego · doi:10.7270/q2nc62f7
BindingDB Entry 50037811: Comparison between two classes of selective EP(3) antagonists and their biological activities.
BindingDB (2012) · UC San Diego · doi:10.7270/q2ns0vq6

Authors: Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
Affiliations: United States Department of Veterans Affairs (US)
ORCID: Breyer, Richard M
Breyer, Matthew D
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2001-04
Volume: 41
Issue: 1
Pages: 661-690
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.41.1.661
OpenAlex: W2129746956
Cited by: 1,011
References: 152
Citations by year: 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 15431)
National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
MeSH terms: Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prostanoid Receptors: Subtypes and Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks